Patents by Inventor Joel Beaudry

Joel Beaudry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for high dose rate brachytherapy treatment planning using constraint optimization
    Patent number: 12728282
    Abstract: Systems and methods for HDR brachytherapy planning can include obtaining patient specific data of a patient, and determining, using the patient specific data, an optimization problem to solve for a single-fraction HDR monotherapy plan including an objective function to be optimized subject to one or more first constraints on radiation doses within one or more OAR regions and a second constraint on radiation doses within the PTV. The systems and methods can include optimizing the objective function subject to the one or more first constraints and the second constraint, determining whether the first single-fraction HDR monotherapy plan satisfies the first and second constraints, updating a bound value of the second constraint based on whether the first single-fraction HDR monotherapy plan satisfies the first and second constraints, and optimizing the objective function subject to the one or more first constraints and the second constraint with the updated bound value.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: September 8, 2026
    Assignees: Memorial Sloan-Kettering Cancer Center, Memorial Hospital for Cancer and Allied Diseases, Sloan-Kettering Institute for Cancer Research
    Inventors: Antonio Damato, Joel Beaudry, Gil'ad Cohen
  • SYSTEMS AND METHODS FOR HIGH DOSE RATE BRACHYTHERAPY TREATMENT PLANNING USING CONSTRAINT OPTIMIZATION
    Publication number: 20250262457
    Abstract: Systems and methods for HDR brachytherapy planning can include obtaining patient specific data of a patient, and determining, using the patient specific data, an optimization problem to solve for a single-fraction HDR monotherapy plan including an objective function to be optimized subject to one or more first constraints on radiation doses within one or more OAR regions and a second constraint on radiation doses within the PTV. The systems and methods can include optimizing the objective function subject to the one or more first constraints and the second constraint, determining whether the first single-fraction HDR monotherapy plan satisfies the first and second constraints, updating a bound value of the second constraint based on whether the first single-fraction HDR monotherapy plan satisfies the first and second constraints, and optimizing the objective function subject to the one or more first constraints and the second constraint with the updated bound value.
    Type: Application
    Filed: April 17, 2023
    Publication date: August 21, 2025
    Inventors: Antonio Damato, Joel Beaudry, Gil Cohen